Dr. Liliana Bustamante Joins Florida Cancer Specialists & Research Institute

Nation's Largest Independent Oncology Group Welcomes New Physician in Lee County

Fort Myers, FL – August 1, 2017. . . Florida Cancer Specialists & Research Institute (FCS), the leading community oncology/hematology practice in the state, is pleased to announce that Liliana Bustamante, MD has joined the practice and is seeing patients at three FCS Locations in Lee County; Dr. Bustamante will practice at the Cay West office, located at 1708 Cape Coral Pkwy West, Suite 10, Cape Coral, FL, the Colonial office at 8931 Colonial Center Drive, Suite 300, Fort Myers, FL and at the North Fort Myers Cancer Center, located at 1030 Commerce Creek Blvd., Cape Coral, FL.

FCS CEO Brad Prechtl said, “We are delighted to welcome Dr. Bustamante to Florida Cancer Specialists. She has established an excellent reputation and will offer added convenience for our patients in Lee County. We are very pleased to have her join the FCS family.”

Dr. William Harwin, Founder and President of FCS, added, "Dr. Bustamante comes to us with excellent outstanding credentials and a keen interest in clinical research.  As a highly dedicated and respected medical oncologist, Dr. Bustamante will be a great addition to our network in the North Fort Myers and Cape Coral communities."

After earning her medical degree from University of Florida, College of Medicine in Gainesville, FL, Dr. Bustamante completed her internship and residency in Internal Medicine at the University of North Carolina in Chapel Hill, NC. In 2014, she was awarded a Fellowship in Hematology/Oncology at the University of South Florida / Moffitt Cancer Center in Tampa, FL.

A native Spanish speaker, Dr. Bustamante has a keen interest in clinical research and has presented at various medical meetings, including the 2015 International Society of Geriatric Oncology’s Annual Conference in Prague and the Annual Scientific Session of the North Carolina Chapter of the American College of Physicians. Dr. Bustamante has also written several book chapters and has been published in several peer-reviewed journals.

Florida Cancer Specialists & Research Institute offers a full range of oncology and hematology services, including clinical research and the use of evidence-based medicine and proactive patient support services. FCS is a strategic site of the Sarah Cannon Research Institute, one of the largest community-based clinical trial organizations in the United States.

##

About Florida Cancer Specialists & Research Institute: (FLCancer.com Founded in 1984, Florida Cancer Specialists & Research Institute (FCS) is the largest independent medical oncology/hematology practice in the United States. With over 200 physicians, 160 nurse practitioners and physician assistants and nearly 100 locations in our network, we are committed to providing world-class cancer care in community-based settings close to home. 

Recognized by the American Society of Clinical Oncology (ASCO) with a national Clinical Trials Participation Award, FCS offers patients access to more clinical trials than any private oncology practice in Florida. 84% of new cancer drugs approved in 2016 for use in the U.S. were studied in clinical trials conducted with FCS participation*. Our physicians are consistently ranked nationally as Top Doctors by U.S. News & World Report.Trained in such prestigious medical schools and research institutes as Duke, Stanford, Harvard, Emory, M.D. Anderson, and Memorial Sloan-Kettering, the physicians of Florida Cancer Specialists provide leadership and consultation in the state's leading hospitals.

FCS serves patients on the Gulf Coast from Naples to the greater Tampa Bay area, north as far as Tallahassee, in Orlando and surrounding Central Florida communities, and on the East Coast from Jacksonville/Fleming Island to Palm Beach County.

Florida Cancer Specialists has built a national reputation for excellence that is reflected in exceptional and compassionate patient care, driven by innovative clinical research and cutting-edge technologies that help advance targeted treatments and genetically-based immunotherapies, and embodied by our outstanding team of highly-trained and dedicated physicians, clinicians and staff.

*Prior to Approval

For More Information, Contact:
Florida Cancer Specialists & Research Institute
Shelly Glenn, Chief Marketing & Sales Officer - SGlenn@FLCancer.com
770.365.6168

ChappellRoberts
Chris Wilkerson - cwilkerson@chappellroberts.com
813.857.7051

Ganick Communications, Inc.
Elaine Ganick - elaine@ganick.com
615.377.7877